Vifor Drug Patent Portfolio
Vifor owns 3 orange book drugs protected by 48 US patents Given below is the list of Vifor's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10624855 | Pharmaceutical composition, comprising phosphate binder particles | 26 May, 2035 | Active |
| US11234938 | Pharmaceutical composition, comprising phosphate binder particles | 26 May, 2035 | Active |
| US11446252 | Pharmaceutical composition, comprising phosphate binder particles | 26 May, 2035 | Active |
| US10624855 | Pharmaceutical composition, comprising phosphate binder particles | 26 Nov, 2034 | Active |
| US11234938 | Pharmaceutical composition, comprising phosphate binder particles | 26 Nov, 2034 | Active |
| US11446252 | Pharmaceutical composition, comprising phosphate binder particles | 26 Nov, 2034 | Active |
| US11123363 | Potassium-binding agents for treating hypertension and hyperkalemia | 08 Oct, 2033 | Active |
| US9492476 | Potassium-binding agents for treating hypertension and hyperkalemia | 08 Oct, 2033 | Active |
| US9925212 | Potassium-binding agents for treating hypertension and hyperkalemia | 08 Oct, 2033 | Active |
| US9561251 | Pharmaceutical compositions | 23 Jul, 2030 | Active |
| US8337824 | Linear polyol stabilized polyfluoroacrylate compositions | 29 May, 2030 | Active |
| US9561251 | Pharmaceutical compositions | 23 Jan, 2030 | Active |
| US10682376 | Pharmaceutical compositions | 13 May, 2029 | Active |
| US10695367 | Pharmaceutical compositions | 13 May, 2029 | Active |
| US10925896 | Pharmaceutical compositions | 13 May, 2029 | Active |
| US10925897 | Pharmaceutical compositions | 13 May, 2029 | Active |
| US10933090 | Pharmaceutical compositions | 13 May, 2029 | Active |
| US11013761 | Pharmaceutical compositions | 13 May, 2029 | Active |
| US11013762 | Pharmaceutical compositions | 13 May, 2029 | Active |
| US10682376 | Pharmaceutical compositions | 13 Nov, 2028 | Active |
| US10695367 | Pharmaceutical compositions | 13 Nov, 2028 | Active |
| US10925896 | Pharmaceutical compositions | 13 Nov, 2028 | Active |
| US10925897 | Pharmaceutical compositions | 13 Nov, 2028 | Active |
| US10933090 | Pharmaceutical compositions | 13 Nov, 2028 | Active |
| US11013761 | Pharmaceutical compositions | 13 Nov, 2028 | Active |
| US11013762 | Pharmaceutical compositions | 13 Nov, 2028 | Active |
| US8147873 | Methods and compositions for treatment of ion imbalances | 20 Jun, 2028 | Active |
| US10017536 | Synthetic peptide amides and dimers thereof | 12 Nov, 2027 | Active |
| US10138270 | Synthetic peptide amides | 12 Nov, 2027 | Active |
| US10793596 | Synthetic peptide amides | 12 Nov, 2027 | Active |
| US7402564 | Synthetic peptide amides | 12 Nov, 2027 | Active |
| US7713937 | Synthetic peptide amides and dimeric forms thereof | 12 Nov, 2027 | Active |
| US7727963 | Synthetic peptide amides | 12 Nov, 2027 | Active |
| US8217007 | Synthetic peptide amides | 12 Nov, 2027 | Active |
| US8236766 | Uses of synthetic peptide amides | 12 Nov, 2027 | Active |
| US8486894 | Synthetic peptide amides and dimeric forms thereof | 12 Nov, 2027 | Active |
| US8536131 | Synthetic peptide amides and dimers thereof | 12 Nov, 2027 | Active |
| US9334305 | Synthetic peptide amides and dimers thereof | 12 Nov, 2027 | Active |
| US9359399 | Synthetic peptide amides | 12 Nov, 2027 | Active |
| US8282913 | Ion binding polymers and uses thereof | 29 May, 2027 | Active |
| US8216560 | Ion binding polymers and uses thereof | 14 Mar, 2027 | Active |
| US7556799 | Ion binding polymers and uses thereof | 27 Feb, 2025 | Expired |
| US10485821 | Ion binding polymers and uses thereof | 30 Mar, 2024 | Expired |
| US8287847 | Ion binding polymers and uses thereof | 30 Mar, 2024 | Expired |
| US8475780 | Ion binding polymers and uses thereof | 30 Mar, 2024 | Expired |
| US8778324 | Ion binding polymers and uses thereof | 30 Mar, 2024 | Expired |
| US8889115 | Ion binding polymers and uses thereof | 30 Mar, 2024 | Expired |
| US6174442 | Adsorbent for phosphate from an aqueous medium, production and use of said adsorbent | 12 Jun, 2020 | Expired |
Latest Legal Activities on Vifor's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Vifor.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 18 Jun, 2024 | US8337824 |
|
Maintenance Fee Reminder Mailed
Critical
| 03 Jun, 2024 | US8287847 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 09 Apr, 2024 | US8282913 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 05 Jan, 2024 | US8216560 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 11 Dec, 2023 | US10695367 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 11 Dec, 2023 | US10682376 |
| transaction for FDA Determination of Regulatory Review Period | 30 Nov, 2023 | US7402564 |
| transaction for FDA Determination of Regulatory Review Period | 28 Nov, 2023 | US7402564 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 09 Oct, 2023 | US10624855 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 06 Oct, 2023 | US10793596 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Sep, 2023 | US8147873 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 07 Aug, 2023 | US8236766 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 12 Jul, 2023 | US8217007 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 12 Jun, 2023 | US9359399 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 17 May, 2023 | US10485821 |
Vifor Drug Patents' Oppositions Filed in EPO
Vifor drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Apr 18, 2016, by Hexal Ag. This opposition was filed on patent number EP09748557A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP08848615A | Sep, 2017 | Interquim S.A. | Revoked |
| EP08848615A | Sep, 2017 | STADA Arzneimittel AG | Revoked |
| EP09748557A | Apr, 2016 | Teva Pharmaceutical Industries Ltd | Patent maintained as amended |
| EP09748557A | Apr, 2016 | Hexal AG | Patent maintained as amended |
Vifor's Family Patents
Vifor drugs have patent protection in a total of 42 countries. It's US patent count contributes only to 29.0% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Vifor Drug List
Given below is the complete list of Vifor's drugs and the patents protecting them.
1. Korsuva
Korsuva is protected by 12 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10017536 | Synthetic peptide amides and dimers thereof |
12 Nov, 2027
(1 year, 10 months from now)
| Active |
| US10138270 | Synthetic peptide amides |
12 Nov, 2027
(1 year, 10 months from now)
| Active |
| US10793596 | Synthetic peptide amides |
12 Nov, 2027
(1 year, 10 months from now)
| Active |
| US7402564 | Synthetic peptide amides |
12 Nov, 2027
(1 year, 10 months from now)
| Active |
| US7713937 | Synthetic peptide amides and dimeric forms thereof |
12 Nov, 2027
(1 year, 10 months from now)
| Active |
| US7727963 | Synthetic peptide amides |
12 Nov, 2027
(1 year, 10 months from now)
| Active |
| US8217007 | Synthetic peptide amides |
12 Nov, 2027
(1 year, 10 months from now)
| Active |
| US8236766 | Uses of synthetic peptide amides |
12 Nov, 2027
(1 year, 10 months from now)
| Active |
| US8486894 | Synthetic peptide amides and dimeric forms thereof |
12 Nov, 2027
(1 year, 10 months from now)
| Active |
| US8536131 | Synthetic peptide amides and dimers thereof |
12 Nov, 2027
(1 year, 10 months from now)
| Active |
| US9334305 | Synthetic peptide amides and dimers thereof |
12 Nov, 2027
(1 year, 10 months from now)
| Active |
| US9359399 | Synthetic peptide amides |
12 Nov, 2027
(1 year, 10 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Korsuva's drug page
2. Velphoro
Velphoro is protected by 23 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10624855
(Pediatric)
| Pharmaceutical composition, comprising phosphate binder particles |
26 May, 2035
(9 years from now)
| Active |
| US11234938
(Pediatric)
| Pharmaceutical composition, comprising phosphate binder particles |
26 May, 2035
(9 years from now)
| Active |
| US11446252
(Pediatric)
| Pharmaceutical composition, comprising phosphate binder particles |
26 May, 2035
(9 years from now)
| Active |
| US10624855 | Pharmaceutical composition, comprising phosphate binder particles |
26 Nov, 2034
(8 years from now)
| Active |
| US11234938 | Pharmaceutical composition, comprising phosphate binder particles |
26 Nov, 2034
(8 years from now)
| Active |
| US11446252 | Pharmaceutical composition, comprising phosphate binder particles |
26 Nov, 2034
(8 years from now)
| Active |
| US9561251
(Pediatric)
| Pharmaceutical compositions |
23 Jul, 2030
(4 years from now)
| Active |
| US9561251 | Pharmaceutical compositions |
23 Jan, 2030
(4 years from now)
| Active |
| US10682376
(Pediatric)
| Pharmaceutical compositions |
13 May, 2029
(3 years from now)
| Active |
| US10695367
(Pediatric)
| Pharmaceutical compositions |
13 May, 2029
(3 years from now)
| Active |
| US10925896
(Pediatric)
| Pharmaceutical compositions |
13 May, 2029
(3 years from now)
| Active |
| US10925897
(Pediatric)
| Pharmaceutical compositions |
13 May, 2029
(3 years from now)
| Active |
| US10933090
(Pediatric)
| Pharmaceutical compositions |
13 May, 2029
(3 years from now)
| Active |
| US11013761
(Pediatric)
| Pharmaceutical compositions |
13 May, 2029
(3 years from now)
| Active |
| US11013762
(Pediatric)
| Pharmaceutical compositions |
13 May, 2029
(3 years from now)
| Active |
| US10682376 | Pharmaceutical compositions |
13 Nov, 2028
(2 years from now)
| Active |
| US10695367 | Pharmaceutical compositions |
13 Nov, 2028
(2 years from now)
| Active |
| US10925896 | Pharmaceutical compositions |
13 Nov, 2028
(2 years from now)
| Active |
| US10925897 | Pharmaceutical compositions |
13 Nov, 2028
(2 years from now)
| Active |
| US10933090 | Pharmaceutical compositions |
13 Nov, 2028
(2 years from now)
| Active |
| US11013761 | Pharmaceutical compositions |
13 Nov, 2028
(2 years from now)
| Active |
| US11013762 | Pharmaceutical compositions |
13 Nov, 2028
(2 years from now)
| Active |
| US6174442 | Adsorbent for phosphate from an aqueous medium, production and use of said adsorbent |
12 Jun, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Velphoro's drug page
3. Veltassa
Veltassa is protected by 13 patents, out of which 6 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11123363 | Potassium-binding agents for treating hypertension and hyperkalemia |
08 Oct, 2033
(7 years from now)
| Active |
| US9492476 | Potassium-binding agents for treating hypertension and hyperkalemia |
08 Oct, 2033
(7 years from now)
| Active |
| US9925212 | Potassium-binding agents for treating hypertension and hyperkalemia |
08 Oct, 2033
(7 years from now)
| Active |
| US8337824 | Linear polyol stabilized polyfluoroacrylate compositions |
29 May, 2030
(4 years from now)
| Active |
| US8147873 | Methods and compositions for treatment of ion imbalances |
20 Jun, 2028
(2 years from now)
| Active |
| US8282913 | Ion binding polymers and uses thereof |
29 May, 2027
(1 year, 4 months from now)
| Active |
| US8216560 | Ion binding polymers and uses thereof |
14 Mar, 2027
(1 year, 2 months from now)
| Active |
| US7556799 | Ion binding polymers and uses thereof |
27 Feb, 2025
(10 months ago)
| Expired |
| US10485821 | Ion binding polymers and uses thereof |
30 Mar, 2024
(1 year, 9 months ago)
| Expired |
| US8287847 | Ion binding polymers and uses thereof |
30 Mar, 2024
(1 year, 9 months ago)
| Expired |
| US8475780 | Ion binding polymers and uses thereof |
30 Mar, 2024
(1 year, 9 months ago)
| Expired |
| US8778324 | Ion binding polymers and uses thereof |
30 Mar, 2024
(1 year, 9 months ago)
| Expired |
| US8889115 | Ion binding polymers and uses thereof |
30 Mar, 2024
(1 year, 9 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Veltassa's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List